Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE = 24.2 +/- 2.1%) were significantly higher than those of p16INK4A present tumors (P.I.= 10.4 +/- 3.5%) (P < 0.05). 10928172

2000

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE Viral infection was more common in poorly differentiated tumors (P=0.032). qRT-PCR demonstrated that CDKN2A (p14ARF) had higher expression in tumor samples compared with paired noncancerous samples (P<0.001). 22878614

2013

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE Both p15 and p16 are tumor suppressor genes that have 5' CpG islands; aberrant cytosine methylation of these islands has been associated with silencing of their expression. 9808523

1998

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE In this study we established the simultaneous status of TP53, p16, p14ARF and PTEN tumor suppressor genes in 34 randomly chosen human glioma cell lines. 10416987

1999

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE The most frequently detected genetic aberrations were mutations in TP53 in 12 tumors(35%) and losses of CDKN2A in9 tumors (26%). 26440310

2015

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE Forty-five of the tumors were p16 positive (p16+), 27 were p16 negative (p16-), and 41 had unknown p16 status. 20225325

2010

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE In the present study we systematically assessed the relative importance of the tumour suppressor proteins p53, p21(Waf1), pRb and p16(INK4a) in mediating oncogene-induced senescence in human melanocytes. 20157537

2009

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 AlteredExpression BEFREE Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. 18331779

2008

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE Methylation of one or more of the genes from the set p14ARF, RASSF1A and APC1A, was significantly (p=0.021) associated with worse prognosis even adjusting for tumor stage and differentiation (RR 2.2, p=0.037). 23128528

2013

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE Inactivation of the CDKN2/p16(INK4A) tumor-suppressor gene is one of the most frequent genetic alterations in human malignancies. 9834265

1998

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 GeneticVariation BEFREE Allelic deletions within this chromosomal region most often include the tumour suppressor gene p16. 12690309

2003

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE We analysed 64 primary lung carcinomas for promoter methylation of the tumour suppressor genes (TSGs) p16 (p16(INK4a)/CDKN2A) and p14 (p14(ARF)) by methylation-specific PCR, in order to evaluate aberrant methylation as a potential biomarker for epigenetic alterations in tobacco-related lung cancer. 12918069

2003

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 GeneticVariation BEFREE HDs were also noted for known tumor suppressor genes (TSG), including CDKN2A, CDKN2B, SMAD4, and GALR1, and identified PDE4D and MGC48628 as potentially novel TSGs. 18519675

2008

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 AlteredExpression BEFREE DAPK1 level in the tumour was significantly higher in females than in males, the MGMT and p16 levels were lower in the tumours with lymph node metastasis (N1 + N2) than in N0 samples. 28421310

2017

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE In this study we explored the relationship between HBx and trimethylation of H3K9 (H3K9me3), and elucidated the underlying mechanisms in HBx inducing the tumor suppressor p16 gene silence. 26341139

2015

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE In 98 samples of colorectal cancer studied, methylation of MGMT, DAPK, p16, hMLH1 and p14 was present in 31, 20, 17, 16 and 14% of tumors, respectively. 15643519

2005

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 GeneticVariation BEFREE Both cell lines showed homozygous deletion of the representative tumor suppressor p16 and p15 genes, but no p53 gene alteration. 10359144

1999

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 GeneticVariation BEFREE Germline mutations in the tumour suppressor gene CDKN2A occur in 5-20% of familial melanoma cases. 24935963

2014

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 GeneticVariation BEFREE Sequencing of each exon of both tumour suppressor genes revealed p16INK4A mutation only in 3 out of 11 BL, but 1 of them also affected the p14ARF gene. 16158958

2005

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 GeneticVariation BEFREE Homozygous deletions of p16 were identified in 5 of 23 (22%) primary tumors; no mutations or rearrangements were found in these specimens. 7923195

1994

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE FAK has been shown to interact with p14ARF (alternative reading frame)#a well-established tumor suppressor#and functions in the negative regulation of cancer through both p53-dependent and -independent pathways. 29966311

2018

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 PosttranslationalModification BEFREE Interestingly, 13 of 21 (62%) MSI-positive tumors and 24 of 67 (36%) MSI-negative tumors had hypermethylation on p16. 10830779

2000

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 AlteredExpression BEFREE Unexpectedly, metastasis was not observed in mice that developed spindle carcinomas, which expressed high levels of the tumour suppressors p16(Ink4a) and p19(Arf) , encoded by Cdkn2a, a gene frequently deleted in human SCCs. 27447534

2016

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE Tumor p16 status was evaluable in 182 patients with OPC enrolled in the IMCL-9815 study; 41% were p16 positive. 26712222

2016

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.500 Biomarker BEFREE These results suggest that mutation of CDK4 can create a tumor-specific antigen and can disrupt the cell-cycle regulation exerted by the tumor suppressor p16INK4a. 7652577

1995